Skip to main content
. 2023 Mar 20;13(2):10–17. doi: 10.5662/wjm.v13.i2.10

Table 1.

Comparison of mandible vs long bone-derived MSCs

Ref.
Features
Mandible derived MSCs
Long bone-derived MSCs
Lee et al[35], 2011 Aspiration time 10 min 2 min
Yamaza et al[28], 2011 No. of colonies 55.3 ± 9.07/ 1.5 × 106 cells/plate (Higher) 5.33 ± 0.58/ 1.5 × 106 cells/plate
Li et al[37], 2019 The appearance of colonies was early within 2-3 d of inoculation into the culture The appearance of colonies of Femur- MSCs was scantly on the 2nd or 3rd day as compared to M-MSCs
Yamaza et al[28], 2011 Osteogenic potential High Low
Matsubara et al[20], 2005 High Low
Aghaloo et al[22], 2010 higher activity of ALP and OCN expression suggesting higher osteogenic potential Comparatively lower osteogenic potential
Li et al[37], 2019 After 21 d, M-MSCs showed loss of morphology, and dry staining was observed; Runx2 gene expression was higher After 21 d, F-MSCs showed obvious cell morphology
Yamaza et al[28], 2011 Doubling rate and cell proliferation High Low
Lee et al[29], 2019 Proliferation time (OD-0.82 ± 0.26) was also documented to be much earlier as compared to F-MSCs but doubling time was lower (22.6 ± 2.22 h) Proliferation time was much delayed (OD-1.13 ± 0.41) as compared to M-MSCs but doubling time was earlier (35 ± 3.19 h)
Li et al[37], 2019 Proliferation time was also documented to be much earlier as compared to F-MSCs Proliferation time was much delayed as compared to M-MSCs
Li et al[37], 2019 Arrangement of cells On day 2, triangular, while after cell (tightly) fusion- these cells are arranged as paving stones On day 2, elongated fibroblast-like morphology, while after cell (tightly) fusion- F-MSCs show vortex-like cloning center
Yamaza et al[28], 2011 Cell expression Positive for MSC-associated markers such as CD-73, -105, and -106, SSEA-4, and Oct-4; Negative for hematopoietic markers such as CD-14, -34, and -45; Expresses SSEA-4 (6.4%) and Oct-4 (6%) in much higher proportion as compared to long bones Positive for MSC-associated markers such as CD-73, -105, and -106, SSEA-4, and Oct-4; Negative for hematopoietic markers such as CD-14, -34, and -45. Expresses SSEA-4 (4.2%) and Oct-4 (2.6%) in lower proportion
Lee et al[35], 2011 Negative for hematopoietic stem cells such as for CD-14, -34, -45, and HLA-DR whereas positive for MSC markers such as CD-29, -44, -73, -90, -105, -166, and HLA-ABC Negative for hematopoietic stem cells such as for CD-14, -34, -45, and HLA-DR whereas positive for MSC markers such as CD-29, -44, -73, -90, -105, -166, and HLA-ABC
Li et al[37], 2019 Strongly expressed CD-29, -73, -90, and -105 but negative for CD-31 and -34 Strongly expressed CD-29, -73, -90, and -105 but negative for CD-31 and -34
Aghaloo et al[22], 2010 Mineralization Mandible BMSC were significantly larger and calcification was also more as compared to long bones; Tissue volume and bone volume was also larger Less calcified as compared to M-MSCs
Lee et al[29], 2019 Mineralization appears within 14 d of osteogenic differentiation (mean-1.57 ± 0.05) The mineral formation is higher (1.98 ± 0.05) as compared to M-MSCs at 14 d
Aghaloo et al[22], 2010 Histology Characterized by increased and mature lamellar bone with marked osteoblastic rimming of bony trabeculae The bone formed was primarily of the cartilaginous matrix with only peripheral bone formation

ALP: Alkaline phosphatase; BMSC: Bone mesenchymal stem cell; HLA: Human leukocyte antigen; MSCs: Mesenchymal stromal cells; M-MSCs: Mandibular-derived MSCs; F-MSCs: Femur-derived MSCs; OCN: Osteocalcin; SSEA-4: Stage-specific embryonic antigen 4; Oct-4: Octamer-4.